SP-43 Management of Acute Odontogenic Pain in the Opioid Overdose Era: Differentiating Drug Seeking From Analgesic Need
CE: 0
Course Description:
The treatment of acute odontogenic pain in the emergency department (ED) is often managed by medical personnel without dental training. Hospital survey data prior to the current opioid overdose epidemic indicate that the majority of patients reporting acute odontogenic pain in the ED received an opioid combination. Recognition that this may be a source of opioids for drug-seeking patients and contribute to drug diversion indicates the need to standardize the management of acute pain both in the ED and in dental settings. This program will summarize the current status of opioid prescribing for acute odontogenic pain, suggest therapeutic strategies to alleviate pain without an opioid, and review guidelines for prescribing opioid combination analgesics for dental outpatients. A draft checklist for prescribing opioids for acute dental pain by ED staff will be presented for review and revision by the attendees for dissemination to the emergency medicine community.
At the conclusion, participants should be able to:
- Identify therapeutic strategies to alleviate pain in patients seeking emergency care.
- Identify when opioid prescriptions are needed.
- Explain how to prescribe opioid combination analgesics.
Key:
Complete
Next
Failed
Available
Locked
Asma A. Khan, BDS, Phd
Dr Asma Khan is a tenured Associate Professor at the University of North Carolina- Chapel Hill. After dental school, Dr Khan completed her PhD in Neuroscience from the University of Maryland and a fellowship in clinical pain research at the NIH. She then moved to University of Texas at San Antonio where she earned a certificate in Endodontics and completed a post-Doctoral fellowship. Her areas of research include Orofacial Pain and Regenerative Endodontics.
Raymond Dionne, D.D.S., M.S. Ph.D.
Dr. Dionne received a DDS from Georgetown University and a PhD from the Medical College of Virginia. He conducted clinical and translational pain research at the National Institute of Dental and Craniofacial Research for 34 years, as well as practiced dentistry part-time in the District of Columbia. He is currently a restless retiree living in Missouri.
Speaker Disclosure
In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: AIM Targeted Therapeutics: Consultant on preclinical development of an investigational analgesic formulation (Ongoing); Rilento Pharma: consultant for pre-clinical development of investigational analgesic formulation (Ongoing)
Asma A. Khan, B.D.S., Ph.D
I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.
Raymond A. Dionne, DDS, MS, PhD
I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.
